EN DE
STOCK COMPARISON

Veeva Systems Inc Class A vs Pro Medicus: Fair Value & Quality

Both stocks run through our valuation models. Here is how Veeva Systems Inc Class A (VEEV) and Pro Medicus (PME) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees Veeva Systems Inc Class A as the less overvalued of the two: Veeva Systems Inc Class A trades at $218 versus a fair value of $95.12 (-56%), while Pro Medicus trades at A$178 versus A$23.74 (-87%).
Veeva Systems Inc Class A
VEEV · USD · Health Care
-56%
upside to fair value
overvalued
Price$218
Fair Value$95.12
Quality63/100
Pro Medicus
PME.AU · AUD · Health Care
-87%
upside to fair value
overvalued
PriceA$178
Fair ValueA$23.74
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Veeva Systems Inc Class APro Medicus
Valuation
33.6×P/E (TTM)88.3×
9.31×P/S (TTM)60.91×
4.28×P/B—
28.7×EV/EBITDA80.9×
0.85×PEG2.67×
—Dividend yield0.3%
—Dividend per shareA$0.62
Profitability
28%Net margin98%
31%Operating margin73%
14%Return on equity77%
7%Return on assets27%
Growth
16%Revenue growth (YoY)28%
14.0%Avg. growth/yr (3Y)31.6%
16.9%Avg. growth/yr (5Y)30.2%
Balance & size
$31BMarket cap$15B
healthyGrowth qualityhealthy

Pro Medicus leads: 4 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Veeva Systems Inc Class Aof which business quality 72 · market factors 43 Pro Medicusof which business quality 81 · market factors 38
ProfitabilityMargins and returns on capital today
57
88
Quality GrowthAre margins and returns improving?
65
79
CashflowEarnings quality: real cash, not paper profit
93
82
Fin. StrengthBalance sheet, leverage, solvency risk
91
100
InvestmentDisciplined investing over empire-building
33
31
Low VolatilityCalm price path (market factor)
56
52
MomentumPrice trend over the last 3–12 months (market factor)
44
42
52W MomentumDistance to the 52-week high (market factor)
26
16
Net IssuanceBuybacks instead of dilution
72
82

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Veeva Systems Inc Class A

DCF Models$210
Earnings-Based$142
Dividend Discount$0.41
Multiples$90.62
Asset-Based$29.76
Growth DCF$193
Economic Profit$57.47
Growth Earnings$178

21 of 26 models see the stock below the current price.

Pro Medicus

DCF ModelsA$32.45
Earnings-BasedA$23.58
MultiplesA$14.72
Asset-BasedA$1.65
Growth DCFA$22.52
Economic ProfitA$14.69
Growth EarningsA$30.99

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Veeva Systems Inc Class A
Bear $71.34Fair Value $95.12Bull $146
$218 = current price (white tick)
Pro Medicus
Bear A$18.20Fair Value A$23.74Bull A$41.92
A$178 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Veeva Systems Inc Class A · Health Care

Quality score63 · Top 25%
Fair value upside-56% · below median

Pro Medicus · Health Care

Quality score67 · Top 25%
Fair value upside-87% · bottom 25%

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees Veeva Systems Inc Class A as the less overvalued of the two: Veeva Systems Inc Class A trades at $218 versus a fair value of $95.12 (-56%), while Pro Medicus trades at A$178 versus A$23.74 (-87%).

Pro Medicus has the higher quality score (67/100).

See the full analysis →
Veeva Systems Inc Class A · Pro Medicus

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Veeva Systems Inc Class A

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Pro Medicus

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.